Synopsis

Multiparametric prostate MRI (mpMRI) protocols that consist of T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), dynamic contrast-enhancing imaging, and T1-weighted imaging provide excellent performance for evaluating prostate cancer (PCa). Recently, abbreviated prostate MRI protocols (or biparametric MRI, bpMRI) that consist of only T2WI and DWI continue to gain support for detecting PCa. It can offer several advantages over mpMRI. In this presentation, my talks would introduce bpMRI protocols and furthermore, advantages and limitations of bpMRI protocols are discussed.